Home > Investors
Corporate Governance
The members and charters for select committees of Enzon’s Board of Directors.
Committe Composition
= add file to Briefcase
| Document | View | ||
|---|---|---|---|
| Governance and Nominating Committee Charter |
|
||
| Compensation Committee |
|
||
| Finance and Audit Committee |
|
||
| Code of Conduct and Corporate Values |
|
||
| California Compliance Declaration |
|
||
To report complaints about Enzon’s accounting, internal accounting controls or auditing matters please call 866-276-2949 at any time of the day or night. You may also submit your complaint by e-mailing enzn@openboard.info or writing to:
Enzon Pharmaceuticals, Inc.Attn: Chief Compliance Officer
685 Route 202/206
Bridgewater, NJ 08807
You may communicate with Enzon’s Board of Directors by writing to:
Enzon Pharmaceuticals, Inc.
Attn: Chief Compliance Officer
685 Route 202/206
Bridgewater, NJ 08807
Stock Information
| (ENZN) NASD | |||
| Last Trade | 9.320 | ||
| Change(%) | |||
| Volume | 12,100 | ||
| May 9, 2008 9:53 AM ET | |||
New Product Release
Our four proprietary marketed brands are ABELCET®, ADAGEN®, DEPOCYT®, and ONCASPAR®. To learn more about our recent product releases CLICK HERE
Shareholder Tools
